A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU) (clinicaltrials.gov) - Aug 15, 2026 - P2 | N=81 | Not yet recruiting | Sponsor: Calixis Inc.
New P2 trial • Chronic Spontaneous Urticaria • Dermatology • Immunology • Urticaria
|